Literature DB >> 30784544

Complicated decisions on new migraine-prevention therapies.

.   

Abstract

Entities:  

Year:  2019        PMID： 30784544     DOI： 10.1016/S1474-4422(19)30041-9

Source DB:  PubMed          Journal:  Lancet Neurol        ISSN： 1474-4422            Impact factor:   44.182


× No keyword cloud information.
  5 in total

1.  Human Urinary Kallidinogenase Reduces Lipopolysaccharide-Induced Neuroinflammation and Oxidative Stress in BV-2 Cells.

Authors:  Zhongyan Zhao; Zhiyu Xu; Tao Liu; Shixiong Huang; Huai Huang; Xiaoyun Huang
Journal:  Pain Res Manag       Date:  2019-07-24       Impact factor: 3.037

2.  Evaluation of injection-site-related adverse events with galcanezumab: a post hoc analysis of phase 3 studies in participants with migraine.

Authors:  Virginia L Stauffer; Shufang Wang; Jo Bonner; ByungKun Kim; Rohit Bhandari; Kathleen A Day; Angelo Camporeale
Journal:  BMC Neurol       Date:  2020-05-19       Impact factor: 2.474

Review 3.  Mechanisms of migraine as a chronic evolutive condition.

Authors:  Anna P Andreou; Lars Edvinsson
Journal:  J Headache Pain       Date:  2019-12-23       Impact factor: 7.277

4.  Dimethyl fumarate alleviates the nitroglycerin (NTG)-induced migraine in mice.

Authors:  Giovanna Casili; Marika Lanza; Alessia Filippone; Michela Campolo; Irene Paterniti; Salvatore Cuzzocrea; Emanuela Esposito
Journal:  J Neuroinflammation       Date:  2020-02-17       Impact factor: 8.322

Review 5.  The Potentials of Uncariae Ramulus Cum Uncis for the Treatment of Migraine: Targeting CGRP in the Trigeminovascular System.

Authors:  Cheong-Meng Chong; Zhangfeng Zhong; Chi Teng Vong; Shengpeng Wang; Jin-Jian Lu; Hai-Jing Zhong; Huanxing Su; Yitao Wang
Journal:  Curr Neuropharmacol       Date:  2021       Impact factor: 7.363
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.